Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhi-qiu Hu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Microbiological Methods|September 8, 2009
A new method for gene synthesis and its high-level expressionShi-shu Cao, Zhi-qiu Hu
Hepatobiliary & Pancreatic Diseases International : HBPD INT|February 9, 2013
Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospectsXi-Qiang Liu, Zhi-Qiu Hu, Yao-Fei Pei, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 12, 2015
Self-management and self-efficacy status in liver recipientsLei Xing, Qin-Yun Chen, Jia-Ning Li, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 17, 2020
MicroRNAs and long non-coding RNAs in liver surgery: Diagnostic and therapeutic meritsZhi-Qiu Hu, Yi Lu, Di Cui, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 10, 2020
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinomaFei Teng, Ju-Xiang Zhang, Qi-Meng Chang, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 29, 2023
Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinomaFei Teng, Ju-Xiang Zhang, Qi-Meng Chang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 10, 2020
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinomaFei Teng, Ju-Xiang Zhang, Qi-Meng Chang, et al.
Clinical Breast Cancer|July 17, 2021
Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 CellsJing-Feng Lu, Zhi-Qiu Hu, Meng-Xuan Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 2, 2019
Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude miceXu-Bo Wu, Xia Feng, Qi-Meng Chang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Microbiological Methods|September 8, 2009
A new method for gene synthesis and its high-level expressionShi-shu Cao, Zhi-qiu Hu
Hepatobiliary & Pancreatic Diseases International : HBPD INT|February 9, 2013
Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospectsXi-Qiang Liu, Zhi-Qiu Hu, Yao-Fei Pei, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|June 12, 2015
Self-management and self-efficacy status in liver recipientsLei Xing, Qin-Yun Chen, Jia-Ning Li, et al.
Hepatobiliary & Pancreatic Diseases International : HBPD INT|May 17, 2020
MicroRNAs and long non-coding RNAs in liver surgery: Diagnostic and therapeutic meritsZhi-Qiu Hu, Yi Lu, Di Cui, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 10, 2020
Correction to: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinomaFei Teng, Ju-Xiang Zhang, Qi-Meng Chang, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 29, 2023
Correction: LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGF R-2 signaling pathway in hepatocellular carcinomaFei Teng, Ju-Xiang Zhang, Qi-Meng Chang, et al.
Journal of Experimental & Clinical Cancer Research : CR|November 10, 2020
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinomaFei Teng, Ju-Xiang Zhang, Qi-Meng Chang, et al.
Clinical Breast Cancer|July 17, 2021
Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 CellsJing-Feng Lu, Zhi-Qiu Hu, Meng-Xuan Yang, et al.
Journal of Experimental & Clinical Cancer Research : CR|March 2, 2019
Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude miceXu-Bo Wu, Xia Feng, Qi-Meng Chang, et al.
Pageof 1